DGAP-Adhoc: Limes Schlosskliniken AG: LIMES Schlosskliniken AG acquires majority shares of Swiss PRC Group AG
DGAP-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Takeover/Takeover
Limes Schlosskliniken AG: LIMES Schlosskliniken AG acquires majority shares of Swiss PRC Group AG
15-Nov-2021 / 11:59 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP-Adhoc: LIMES Schlosskliniken AG:
LIMES Schlosskliniken AG acquires majority shares of Swiss PRC Group AG
LIMES Schlosskliniken AG, Cologne/Zurich, 15.11.2021. LIMES Schlosskliniken AG acquired 51% of the Swiss PRC Group AG. The remaining 49% will be held by the management of the company.
PRC Group AG runs the world's most exclusive, individual and discreet clinic for addiction and mental health treatments under the brand "Paracelsus Recovery". With teams of 15 doctors and therapists per patient, the clinic treats mainly affluent international patients and celebrity clients.
PRC and LIMES would like to significantly expand the treatment options for international clients. The merger provides the best conditions for this strategy.
The Paracelsus Recovery clinic plans to achieve sales of EUR 8 million and an operating result (EBITDA) of EUR 2.5 million in 2022. The clinic will contribute earnings per share of EUR 4.2 to LIMES consolidated net income after minority interests.
The transaction is financed from liquid funds of the LIMES Group as well as shareholder loans.
Company profiles:
Paracelsus Recovery was founded in 2013 as a family-owned clinic and has established itself as the world's leading clinic for addiction and mental illness. Besides its base in Zürich, since 2019 the clinic also treats patients in London. Furthermore, the clinic sends individual therapists and whole teams to support patients worldwide in their homes. The exclusive treatment offers are catering to an affluent international clientele such as business owners, top executives and public figures, as well as their family members, who seek not only the best possible and most intensive treatment options, but require strict confidentiality and a luxurious environment. More information can be found at www.paracelsus-recovery.com.
The LIMES Schlosskliniken Group operates high-quality private clinics in Germany for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to state aid and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de.
Your contact person:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Tel.: 02203 / 29014-202, [email protected], www.limes-schlosskliniken.de
Language: English
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Köln, Germany
ISIN: DE000A0JDBC7
WKN: AOJDBC
Stock exchange Düsseldorf Freiverkehr, Primärmarkt, XETRA
End of the message
15-Nov-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
|
Language: |
English |
Company: |
Limes Schlosskliniken AG |
|
Kaiser-Wilhelm-Ring 26 |
|
50672 Köln |
|
Germany |
ISIN: |
DE000A0JDBC7 |
WKN: |
A0JDBC |
Listed: |
Regulated Unofficial Market in Dusseldorf |
EQS News ID: |
1249037 |
|
End of Announcement |
DGAP News Service |
1249037 15-Nov-2021 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Umsatzerlöse1 |
6,54 |
7,43 |
8,18 |
11,02 |
23,44 |
28,81 |
37,17 |
EBITDA1,2 |
-0,49 |
-0,13 |
0,26 |
0,84 |
6,02 |
8,65 |
7,67 |
EBITDA-Marge3 |
-7,49 |
-1,75 |
3,18 |
7,62 |
25,68 |
30,02 |
|
EBIT1,4 |
-0,72 |
-0,93 |
-0,54 |
-0,43 |
4,53 |
6,00 |
5,03 |
EBIT-Marge5 |
-11,01 |
-12,52 |
-6,60 |
-3,90 |
19,33 |
20,83 |
13,53 |
Jahresüberschuss1 |
-1,25 |
-1,46 |
-0,83 |
-0,69 |
4,11 |
4,86 |
3,91 |
Netto-Marge6 |
-19,11 |
-19,65 |
-10,15 |
-6,26 |
17,53 |
16,87 |
10,52 |
Cashflow1,7 |
1,02 |
-0,66 |
0,17 |
0,76 |
4,77 |
8,04 |
6,29 |
Ergebnis je Aktie8 |
-4,95 |
-5,78 |
-2,81 |
-2,37 |
13,45 |
14,34 |
11,58 |
Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: B-S-H Collegen
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Limes Schlosskliniken |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
A0JDBC |
332,000 |
Kaufen |
97,34 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
19,64 |
21,43 |
0,91 |
70,71 |
KBV |
KCV |
KUV |
EV/EBITDA |
6,43 |
15,47 |
2,62 |
12,89 |
Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23 in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
10.06.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
|
03.09.2024 |
|
13.05.2024 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
-6,32% |
-5,06% |
16,90% |
23,88% |
|
|